Related Experiment Video
Updated: Jul 16, 2025

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
Mitochondrial IRG1 traps MCL-1 to induce hepatocyte apoptosis and promote carcinogenesis
Liyuan Zhang1, Yue Dong1, Luxin Zhang1
1National Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai, 200433, China.
Abstract:
Hepatocarcinogenesis is initiated by repeated hepatocyte death and liver damage, and the underlying mechanisms mediating cell death and the subsequent carcinogenesis remain to be fully investigated. Immunoresponsive gene 1 (IRG1) and its enzymatic metabolite itaconate are known to suppress inflammation in myeloid cells, and its expression in liver parenchymal hepatocytes is currently determined. However, the potential roles of IRG1 in hepatocarcinogenesis are still unknown. Here, using the diethylnitrosamine (DEN)-induced hepatocarcinogenesis mouse model, we found that IRG1 expression in hepatocytes was markedly induced upon DEN administration. The DEN-induced IRG1 was then determined to promote the intrinsic mitochondrial apoptosis of hepatocytes and liver damage, thus enhancing the subsequent hepatocarcinogenesis. Mechanistically, the mitochondrial IRG1 could associate and trap anti-apoptotic MCL-1 to inhibit the interaction between MCL-1 and pro-apoptotic Bim, thus promoting Bim activation and downstream Bax mitochondrial translocation, and then releasing cytochrome c and initiating apoptosis. Thus, the inducible mitochondrial IRG1 promotes hepatocyte apoptosis and the following hepatocarcinogenesis, which provides mechanistic insight and a potential target for preventing liver injury and HCC.
Insights
Immunoresponsive gene 1 (IRG1) promotes liver cancer by inducing hepatocyte apoptosis. This finding reveals IRG1 as a potential therapeutic target for preventing liver injury and hepatocellular carcinoma (HCC).
Area of Science:
- Hepatology
- Molecular Biology
- Cancer Research
Background:
- Hepatocarcinogenesis involves hepatocyte death and liver damage, with underlying mechanisms requiring further investigation.
- Immunoresponsive gene 1 (IRG1) and itaconate are known to regulate inflammation in myeloid cells, but their role in liver parenchymal cells and hepatocarcinogenesis is unclear.
Purpose of the Study:
- To investigate the role of IRG1 in diethylnitrosamine (DEN)-induced hepatocarcinogenesis.
- To elucidate the mechanisms by which IRG1 influences hepatocyte apoptosis and liver injury.
Main Methods:
- Utilized a diethylnitrosamine (DEN)-induced mouse model of hepatocarcinogenesis.
- Assessed IRG1 expression in hepatocytes following DEN administration.
- Investigated the molecular mechanisms of IRG1-mediated apoptosis, including mitochondrial localization and protein interactions.
Main Results:
- Hepatocyte IRG1 expression was significantly induced by DEN administration.
- DEN-induced IRG1 promoted intrinsic mitochondrial apoptosis of hepatocytes and exacerbated liver damage, thereby enhancing hepatocarcinogenesis.
- Mitochondrial IRG1 was found to bind MCL-1, inhibiting its interaction with Bim, leading to Bim activation, Bax translocation, and apoptosis initiation.
Conclusions:
- Inducible mitochondrial IRG1 promotes hepatocyte apoptosis and subsequent hepatocarcinogenesis.
- IRG1 plays a critical role in liver injury and the development of hepatocellular carcinoma (HCC).
- IRG1 represents a potential therapeutic target for preventing liver injury and HCC.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Intrinsic Apoptotic Pathway
Mutagenicity and Carcinogenicity
Regulation of the Unfolded Protein Response
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...

